CuraGen
CuraGen officials detail recent developments
Published in Hospital Law Weekly, March 1st, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at CuraGen.
Report 1: CuraGen Corporation (CRGN) and TopoTarget A/S (TOPO) announced updated results from a Phase Ib trial of PXD101, a small molecule histone deacetylase (HDAC) inhibitor, in combination with carboplatin and paclitaxel in patients with advanced solid tumors, along with three additional posters on PXD101, were presented at the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, held in Prague, Czech Republic.
Updated results were presented in a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2007-03-01)
More Articles from Hospital Law Weekly
- HIV/AIDS Research
Rand study finds few HIV-positive parents make formal guardianship arrangements for their children - Internal Medicine
Reports on internal medicine findings from Baylor College of Medicine provide new insights - Legal Issues
Consejo announces major settlement with HMA Hospitals - Life Sciences Prevention
Research results from Dalhousie University update knowledge of life sciences prevention - Pathology
New pathology study findings have been reported by scientists at Massachusetts General Hospital - Abdominal Aortic Aneurysm Epidemiology
Data on abdominal aortic aneurysm epidemiology detailed by researchers at Viborg Hospital, Department of Vascular Surgery - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
